Activity OverviewThe Advanced Rheumatology Course is a 19-activity series for advanced practice providers and other professionals who need a deeper dive into rheumatology. The series covers how to assess and manage patients with rheumatic disease, develop strategies to integrate NP/PAs into rheumatology practice, and improve access to care for patients. The advanced information will help experienced practice providers function well in rheumatology and foster inter-professional collaboration. Advanced Rheumatology Course SeriesThis activity includes all activities in the series.Activity 1: Musculoskeletal Structure And Function And Inflammation And ImmunityActivity 2: Framework for Clinical Decision Making in RheumatologyActivity 3: Laboratory Evaluation of Rheumatic DiseaseActivity 4: Imaging of ArthritisActivity 5: Coding And Practice IssuesActivity 6: Therapeutic Interventions And ResourcesActivity 7: OsteoarthritisActivity 8: RA and Seronegative Inflammatory ArthropathiesActivity 9: Systemic Lupus ErythematosusActivity 10: Systemic Inflammatory Conditions: Inflammatory MyopathyActivity 11: Vasculitis, Arteritis and PMRActivity 12: Crystal-Induced ArthropathiesActivity 13: Pain SyndromesActivity 14: SpondyloarthritisActivity 15: Infection-Related ArthritisActivity 16: Osteoporosis And Other Metabolic Bone DisordersActivity 17: Comprehensive Overview of Juvenile Idiopathic Arthritis (JIA)Activity 18:Comprehensive Overview of Pediatric Connective Tissue Diseases (CTD)Activity 19: Pediatric Noninflammatory Musculoskeletal PainRegistration is discounted for ACR/ARP members. If you are not a member, consider joining ACR/ARP.Target AudienceAdvanced practice nurses and physician assistants. Fellows-in training, residents, students, primary care providers, physical therapists, and researchers may also benefit.Learning ObjectivesUpon completion of this activity, participants should be able to: Assess and manage patients with rheumatic diseases as part of an interprofessional collaborative care teamDevelop strategies to integrate the nurse practitioner and physician assistant into a collaborative rheumatology practiceAssist in decreasing wait times for appointments and improve access to care for patients with rheumatic disease by improving the competence and performance of nurse practitioners and physician assistants in a collaborative rheumatology practice CE & MOC InformationCMEACCME Accreditation StatementThe American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AMA Designation Statement The American College of Rheumatology designates this enduring material for a maximum of 25.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. See the ACR's CME Mission Statement. For more information, download the AMA PRA Booklet.CME credit must be claimed by August 14, 2026, at 11:59 PM ET. Financial Relationships Disclosures ACR Disclosure Statement It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at http://accme.org . In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity. Nature of Financial Relationships All individuals involved or able to influence the content of this accredited activity have disclosed to the editorial team and audience any/all financial or other relationship(s) including, but not limited to: Advisor or review panel memberConsultantEmployeeOfficer or Board MemberGrant/research supportSpeaker/honoraria includes speaker’s bureau, symposia, and expert witnessIndependent contractorExecutive role and/or ownership interestRoyalties and/or patent beneficiaryIntellectual property/patentsStock options or bond holdings in a for-profit corporation or self-directed pension planPrivate investigatorExpert witnessEquity interestOther: specify detailsNone: Has no relevant financial relationship(s) with ineligible companies to disclose. All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.  ARC01: Musculoskeletal Structure And Function And Inflammation And Immunity Authors/Planners Kenneth S. O’Rourke, MD - No relevant financial relationships to discloseRachel M. Wolfe, MD - No relevant financial relationships to disclose Editors and Reviewers Daniel Schaffer, MD – No relevant financial relationships to discloseAnneke Smith – No relevant financial relationships to discloseBen Smith, DMSc, PA-C, DFAAPA – No relevant financial relationships to disclose   ARC02: Framework for Clinical Decision Making in Rheumatology Author Megan Lockwood, MD - No relevant financial relationships to disclose Editors and Reviewers Jennifer Grossman, MD - No relevant financial relationships to discloseAnneke Smith – No relevant financial relationships to discloseSonam Kiwalkar, MD – No relevant financial relationships to disclose   ARC03:  Laboratory Evaluation of Rheumatic Disease Author Beth Jonas, MD – No relevant financial relationships to discloseEditors and Reviewers Laurie Hughell, MPH, PA-C - No relevant financial relationships to disclose Anneke Smith – No relevant financial relationships to discloseBen Smith, DMSc, PA-C, DFAAPA – No relevant financial relationships to disclose   ARC04: Imaging of Arthritis Author Beth Jonas, MD – No relevant financial relationships to disclose Editors and Reviewers Laurie Hughell, MPH, PA-C - No relevant financial relationships to discloseAnneke Smith – No relevant financial relationships to discloseBen Smith, DMSc, PA-C, DFAAPA – No relevant financial relationships to disclose   ARC05: Coding And Practice Issues Author J. Eugene Huffstutter, MD - No relevant financial relationships to disclose Editors and Reviewers Fredrica Smith, MD - No relevant financial relationships to discloseJulie Lahti - No relevant financial relationships to discloseBen Smith, DMSc, PA-C, DFAAPA - No relevant financial relationships to disclose   ARC06: Therapeutic Interventions And Resources Authors/Planners Donna Everix, MPH, PT - No relevant financial relationships to discloseJennifer Trizuto, DPT - No relevant financial relationships to disclose Editors and ReviewersMarie Westby, PT, PhD - Janssen Canada5; Ended 2020; Pfizer5; Ended 2020Julie Lahti - No relevant financial relationships to discloseBen Smith, DMSc, PA-C, DFAAPA - No relevant financial relationships to disclose   ARC07: Osteoarthritis Authors/Planners Abhijeet Danve, MD – AbbVie/Abbott1; Novartis1 Yuliya Afinogenova, MD - No relevant financial relationships to disclose Swetha Alexander, MD - No relevant financial relationships to disclose Editors and Reviewers Janeth Yinh, MD – No relevant financial relationships to disclose Anneke Smith – No relevant financial relationships to disclose Sonam Kiwalkar, MD – No relevant financial relationships to disclose   ARC08: RA and Seronegative Inflammatory Arthropathies Author Gregory C. Gardner, MD, MACP – No relevant financial relationships to disclose Editors and Reviewers Sheila Arvikar, MD – No relevant financial relationships to discloseJulie Lahti - No relevant financial relationships to discloseSonam Kiwalkar, MD – No relevant financial relationships to disclose   ARC09: Systemic Lupus Erythematosus Authors/Planners Mary Chester Wasko, MD, AbbVie/Abbott2; AstraZeneca2; EMD Serono2; GlaxoSmithKlein2; HGS2; Roche2Joanna Marco, MD – No relevant financial relationships to disclose Editors and Reviewers Paul Monach, MD, PhD – Celgene1; Chemocentryx6; Kiniksa16Anneke Smith – No relevant financial relationships to discloseMarcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2   ARC10: Systemic Inflammatory Conditions Authors/Planners Jason Kolfenbach, MD: ChemoCentryx5 Tara Skorupa, MD: No relevant financial relationships to disclose Editors and Reviewers Zsuzsanna McMahon – No relevant financial relationships to discloseMarcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2Julie Lahti – No relevant financial relationships to disclose   ARC11: Vasculitis, Arteritis and PMR Authors/Planners Anisha Dua, MD - AbbVie/Abbott5, 8; ChemoCentryx5; Novartis5Josh Waytz, MD – No relevant financial relationships to disclose Editors and Reviewers Paul Monach, MD, PhD – Celgene1; Chemocentryx6; KiniksaAnneke Smith – No relevant financial relationships to discloseMarcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2   ARC12:  Crystal-Induced Arthropathies Author Puja Khanna, MD – DYVE2; Horizon1,2,5; Select1,2 Editors and Reviewers Chio Yokose, MD – No relevant financial relationships to discloseAnneke Smith – No relevant financial relationships to discloseSonam Kiwalkar, MD – No relevant financial relationships to disclose   ARC13: Pain Syndromes Author Andrew Heisler, MD – No relevant financial relationships to disclose Editors and Reviewers Sonam Kiwalkar, MD – No relevant financial relationships to discloseChristine Stamatos, DNP – No relevant financial relationships to disclose Julie Lahti – No relevant financial relationships to disclose   ARC14: Spondyloarthritis Authors/Planners Atul Deodhar, MD -  AbbVie/Abbott528;  Amgen528;  BMS528;  Boheringer Ingelheim528;  Celgene528;  Gilead528;  Glapagos528;  Janssen528;  Lilly528;  Novartis528;  Pfizer528;  UCB528Anand Kumthekar, MD – No relevant financial relationships to disclose Editors and Reviewers Abhijeet Danve, MD – AbbVie/Abbott1; Novartis1Anneke Smith – No relevant financial relationships to discloseSonam Kiwalkar, MD – No relevant financial relationships to disclose   ARC15: Infection-Related Arthritis Authors/Planners Robert A. Kalish, MD – No relevant financial relationships to discloseJanet Hong, MD – No relevant financial relationships to discloseFrank Scangarello, MD, PhD – No relevant financial relationships to disclose Editors and Reviewers Michael Battistone, MD – American Board of Internal Medicine Rheumatology Exam Committee6: Advisor or Review Panel memberAnneke Smith – No relevant financial relationships to discloseMarcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2   ARC16: Osteoporosis And Other Metabolic Bone Disorders Author Sarah Keller, MD – No relevant financial relationships to disclose Editors and Reviewers Alfred Denio, MD –  Abbvie8; Bristol-Myers Squibb5Marcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2Julie Lahti – No relevant financial relationships to disclose   ARC17: Comprehensive Overview of Juvenile Idiopathic Arthritis (JIA) Author Betsy Roth-Wojcicki, RN, MS, CPNP-PC - No relevant financial relationships to disclose Editors and Reviewers Heather Benham, APRN, CPNP, DNP, RhMSUS – No relevant financial relationships to discloseAnneke Smith - No relevant financial relationships to discloseBen Smith, DMSc, PA-C, DFAAPA – No relevant financial relationships to disclose   ARC18: Comprehensive Overview of Pediatric Connective Tissue Diseases (CTD) Author Heather Benham, DNP, APRN, CPNP-PC, RhMSUS – No relevant financial relationships to disclose Editors and Reviewers Natasha Ruth, MD, MS – No relevant financial relationships to discloseMarcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2Julie Lahti – No relevant financial relationships to disclose   ARC19: Pediatric Noninflammatory Musculoskeletal Pain Author Bethany A. Marston, MD – No relevant financial relationships to disclose Editors and Reviewers Susan Shenoi, MS, MBBS, RhMSUS – Pfizer5Julie Lahti - No relevant financial relationships to discloseSonam Kiwalkar, MD – No relevant financial relationships to disclose *All of the relevant financial relationships listed for these individuals have been mitigated.Acknowledgement of Commercial Support The project was supported by Grant number 1 NU58DP006908-03-00 – Component A; Developing and Disseminating Programs to Build Sustainable Lupus Awareness, Knowledge, Skills and Partnerships. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Health and Human Services, Centers for Disease Control and Prevention.Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.